NQO1 and pancreatic ductal adenocarcinoma: Awadallah et al.[10] and Lyn-Cook et al.[8] found that NQO1 was not only upregulated in pancreatic ductal adenocarcinoma (PDAC), but could also minimize the risk of false positive diagnosis by combining NQO1 expression with cellular morphology assessment.